- In April 2022, Anelto and BioIntelliSense announced a strategic partnership to enhance remote patient monitoring for seniors. This collaboration integrates BioIntelliSense’s FDA-cleared BioSticker and BioButton wearable devices with Anelto’s RemoteCareLive! platform. The integration enables continuous, passive monitoring of vital signs, allowing healthcare providers to track patient health data in near real-time. This development aims to improve care for seniors with chronic conditions by providing consistent monitoring and timely interventions. The partnership is expected to impact the market by expanding the adoption of advanced remote monitoring solutions, particularly among senior populations requiring ongoing health management
- In March 2022, Alder Hey Children’s NHS Foundation Trust partnered with Isansys Lifecare to implement at-home patient monitoring for young patients. Utilizing Isansys' Patient Status Engine (PSE), the collaboration enables continuous, real-time monitoring of vital signs such as heart rate, respiration rate, oxygen saturation, blood pressure, and body temperature. Clinicians can access this data remotely via mobile devices or central monitoring stations, integrating it into electronic medical records for comprehensive care. This initiative aims to reduce hospital admissions and readmissions by allowing patients to receive personalized care plans at home, thereby alleviating pressure on healthcare facilities. The partnership is expected to enhance patient outcomes through timely interventions and more efficient use of healthcare resources
